Insider buying last 90 days
No open-market insider purchases were filed for AGX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Argan shares fell despite record fiscal second-quarter results, as attention centered on a decline in backlog to $2.5 billion from $2.9 billion, along with industrial segment margins that fell short of expectations due to cost overruns. The quarter itself showed record revenue of $384 million, with Power segment revenue up 53% to $301 million, Industrial up 111% to $76 million, and Teledata up 40% to $7 million, alongside net income of $53.3 million and adjusted EBITDA margin of 18.2%. The company also acquired ValCor Communications to expand its Teledata business in New England.
Argan trades at $306.28, down 10.4%, sitting below both its 50-day average of $370.09 and 200-day average of $518.83, with the 50-day also below the 200-day. The GekkoIndex reads 66.3, placing the stock in the Accumulation zone. Price sits 16.9% below Gekko Fair Value of $368.39.
Argan next reports earnings on 3 December 2026, after the close, 18 days away and within a typical 20-trading-day holding window; its last eight quarters all beat estimates, with an average absolute reaction of 9.3%. Seasonality over the past 5 years shows an average 20-trading-day return of 0.8% from this point in the calendar, with gains in 3 of those years. No insider, Congress or unusual options activity appears in the relevant windows, though two billionaire holders and one trailblazer holder are noted among current holders.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Argan scores 2 supportive, 0 mixed and 3 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive0 mixed3 headwinds
Below 50 and 200-day
Close $306.48 is below the 50-day ($362.02) and 200-day ($517.92) averages, and the 50-day is below the 200-day.
See the chart61.1, Accumulation
Reading 61.1 is in the Accumulation zone.
See the GekkoIndex16.1% below
Price is 16.1% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 18 days
Reports on Dec 3, 2026, 18 days away — inside a typical 20-trading-day hold.
See earnings−7.3% on average
From this point in the calendar, the next 20 trading days averaged −7.3% over 5 years, rising in 0 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Argan closed at $306.48 on Nov 13, 2026, −16.0% over the past year, inside a 52-week range of $252.88 to $805.75.
Use the left and right arrow keys to read daily values.
Put AGX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Argan provides construction and support services to companies building and running power plants, with particular depth in renewable energy work. Its history includes involvement in projects that together represent close to 15 gigawatts of generating capacity, spanning biomass facilities, wind installations, and solar arrays, alongside design, start-up, and long-term operational support for power facilities generally.
The company groups its work into three divisions. One handles construction and engineering for power generation clients, including independent developers, utilities, equipment makers, and other firms building energy plants. A second division performs fabrication of pipes and vessels plus on-site industrial services for sectors such as paper and wood products, industrial gases, fertilizer manufacturing, and mining, with most of this activity concentrated in the southeastern part of the country. The third division builds and services communications and electrical networks, covering tasks like boring for underground lines, running aerial and buried cable, installing voltage lines and outdoor lighting, and setting up cabling for data and security systems, working with local and federal government clients, communications firms, utilities, and businesses mainly across the mid-Atlantic.
Argan traces back to 1961 and runs its operations from Rockville, Maryland. Its common stock trades on the NYSE under the ticker AGX.
Argan’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 61.1, in the Accumulation zone, down 10.4 points over five sessions.
Down 10.4 points over five sessions, from the Buying zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 21 | +2.2% | −2.6% | ||
| Accumulation (current zone) | 135 | +2.3% | +3.9% | ||
| Neutral | 477 | +1.9% | +9.1% | ||
| Distribution | 66 | −0.8% | +4.5% | ||
| Selling | 3 | Too few readings yet | |||
Average AGX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Argan trades 16.1% below Gekko Fair Value of $365.18, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Argan shares are worth, recalculated every trading day.
$365.18
Gekko Fair Value, Nov 14, 2026
16.1% Undervalued
At the end of Aug 2026 the price was 7.4% below the estimate.
No open-market insider purchases were filed for Argan, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for AGX in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in AGX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Argan has been buying back its own shares.
From company filings.
3of the funds Gekko tracks hold AGX.
Argan reports on Dec 3, 2026, after the close (18 days away), and beat the EPS estimate in 8 of its last 8 reports.
Dec 3, 2026
Expected after the close, 18 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Sep 2, 2026 | $3.76 est $2.68 | $384.0M est $300.5M | +1.7% |
| Jun 4, 2026 | $3.24 est $2.33 | $291.0M est $256.0M | +1.2% |
| Mar 26, 2026 | $3.47 est $1.99 | $262.1M est $255.3M | +29.5% |
| Dec 4, 2025 | $2.17 est $2.05 | $251.2M est $263.8M | −10.6% |
| Sep 4, 2025 | $2.50 est $1.99 | $237.7M est $243.0M | −6.8% |
| Jun 4, 2025 | $1.60 est $1.09 | $193.7M est $193.8M | +7.6% |
| Mar 27, 2025 | $2.22 est $1.15 | $232.5M est $197.5M | +15.6% |
| Dec 5, 2024 | $2.00 est $1.26 | $257.0M est $225.6M | −1.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Argan is $570.50, +86.1% from the last close, from 7 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 7 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 29 | J.P. Morgan | $785 | +156.1% |
| Sep 14 | Goldman Sachs | $565 | +84.4% |
| Sep 8 | Bank of America Securities | $273 | −10.9% |
| Sep 8 | Piper Sandler | $273 | −10.9% |
| Sep 4 | Freedom Capital Markets | $700 | +128.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Argan averaged −7.3% across the last 5 years, rising in 0 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.1% | 2 of 5 |
| Next 10 trading days | −0.5% | 4 of 5 |
| Next 15 trading days | −2.0% | 2 of 5 |
| Next 20 trading days | −7.3% | 0 of 5 |
| Next 30 trading days | −5.2% | 1 of 5 |
For scale, AGX’s typical 20-trading-day move in either direction is about 7.2%.
Argan’s market cap is $4.30B, with a P/E ratio of 24.9 and revenue of $1.19B over the last twelve months.
Coverage of Argan this week reads positive: 2 positive, 1 neutral and 0 negative headlines.
Argan’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PWRQuanta Services | Neutral | 1.1% above |
| FERFerrovial | Neutral | 6.3% below |
| FIXComfort Systems USA | Accumulation | 19.6% below |
| OTISOtis Worldwide | Neutral | 0.7% below |
| EMEEMCOR | Accumulation | 4.2% above |
| APGAPi | Neutral | 8.9% above |
A peer links to its own page where one exists.
Argan’s market cap is $4.30B at the Nov 13, 2026 close of $306.48, with 14.03M shares outstanding. The shares trade on a P/E ratio of 24.9.
The consensus analyst 12-month price target for Argan is $570.50, +86.1% from the last close. Of the 7 firms that rated the stock in the last 90 days, 4 rate it a buy, 1 a hold and 2 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Argan is undervalued: the Nov 13, 2026 close of $306.48 is 16.1% below Gekko Fair Value of $365.18. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Argan is expected to report on Dec 3, 2026, after the market closes (18 days away). Analysts expect earnings of $3.14 per share on revenue of $358.8M. Argan beat the earnings estimate in 8 of its last 8 reports, moving 9.3% on average across the report.
Argan’s 52-week high is $805.75 and its 52-week low is $252.88; it closed at $306.48 on Nov 13, 2026, −16.0% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and fair value) and 3 as headwinds (trend, earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.